Pharma major Dr. Reddy’s Laboratories and Nasdaq-listed global biotech firm Alvotech will co-develop, manufacture and commercialise a biosimilar candidate to Merck’s cancer drug Keytruda ...

La correduría proyecta ingresos por semaglutida de Dr Reddy’s en $280 millones en 2027, contribuyendo aproximadamente 18% a las ganancias por acción de la compañía, con la mayoría de esas ventas ...

Dr Reddy's Laboratories on Saturday said the US health regulator has issued a Form 483 with two observations after inspecting its US-based facility. The US Food and Drug Administration completed a ...

The cable channel, which is set to be spun off from NBC, is starting its first stand-alone D.C. office with Sudeep Reddy at the helm. It also plans to hire 100 new journalists. By Michael M.

Dr Reddy’s Laboratories is stepping up its focus on the domestic market with a multi-pronged strategy. The Hyderabad-based drug maker began to focus on bringing innovative drugs to the Indian ...

Amid growing concerns about potential US import tariffs on pharmaceuticals, Indian generics giant Dr. Reddy's Laboratories is taking steps to secure its supply chain for key products entering the ...

In the glitzy and glamorous world of Bollywood, people are obsessed with staying fit and looking young. Many people resort to beauty trends to get quicker results. Real transformation requires ...

A special CBI court here on Tuesday convicted former Karnataka minister and MLA Gali Janardhan Reddy and three others in the Obulapuram Mining Company (OMC) illegal mining case. The court ...

Hyderabad: After over 14 years, a special CBI court here on Tuesday sentenced Karnataka former minister and ‘mining baron’ Gali Janardhan Reddy, his brother-in-law B.V. Srinivasa Reddy and ...

VIJAYAWADA: Former Rajya Sabha MP V Vijayasai Reddy appeared before the Special Investigation Team (SIT) at the Vijayawada City Police Commissionerate on Friday in connection with the alleged Rs ...

Pharmaceutical major Dr Reddy's Laboratories has denied the news report by Business Standard claiming it is looking at a 25 percent workforce cost reduction, calling it 'factually incorrect', in ...